Last reviewed · How we verify

NCT04013308

Iontophoresis With Potassium Iodide and Thyroid Function

Completed NA Last updated 15 August 2019
What this trial tests

NA trial testing Iontophoresis with 2% potassium iodide in Thyroid Dysfunction in 56 participants. Completed in 31 July 2019.

Timeline
27 May 2019
Primary endpoint
30 July 2019
31 July 2019

Quick facts

Lead sponsorUniversity of Rzeszow
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment56
Start date27 May 2019
Primary completion30 July 2019
Estimated completion31 July 2019
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University of Rzeszow

Who can join

Adults 19 to 23, any sex, with Thyroid Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study: To assess the influence of iontophoresis treatment with 2% potassium iodide on the level of thyroid hormones (TSH, FT3, FT4) The study group: conducting 10 iontophoresis treatments with Potassium iodide; The control group: conducting 10 placebo treatments with iontophoresis with destilled water; Intervention: 10 iontophoresis treatments with 2% potassium iodide in healthy individuals. Test the level of thyroid hormones before and after the 10 iontophoresis treatments; The study allows to assess the influence of iodine on the function of thuroid gland.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of galvanization and potassium iodide iontophoresis of the throat and larynx on thyroid parameters: a randomized controlled trial.
    Zwolińska J, Augustyn B, Baj K, Krukowska J. · · 2021 · PMID 34341406 · DOI 10.1038/s41598-021-95145-w

Verify or expand the search:

Other recruiting trials for Thyroid Dysfunction

Currently open trials in the same condition.

Other University of Rzeszow trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04013308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing